Cost–Benefit Evaluation of Interferon and Ribavirin for the Treatment of Hepatitis C in District Dera Ismail Khan, Pakistan. JPEHSS [Internet]. 2026 Feb. 4 [cited 2026 May 6];4(1):129-36. Available from: https://journal-of-social-education.org/index.php/Jorunal/article/view/1040